Monotropein alleviates sepsis-elicited acute lung injury via the NF-κB pathway

Objectives: To address the effect and mechanism of Monotropein (Mon) on sepsis-induced acute lung injury (ALI).

Methods: ALI model was established by lipopolysaccharide (LPS)-stimulated mouse lung epithelial cell lines (MLE-12) and cecal ligation and puncture (CLP)-treated mice, respectively. The function of Mon was examined by cell counting kit-8 (CCK-8), pathological staining, the pulmonary function examination, flow cytometry, enzyme-linked immunosorbent assay, terminal deoxynucleotidyl transferase deoxyuridine triphosphate nick end labellingand western blot.

Results: Mon increased the LPS-reduced viability but decreased the LPS-evoked Apoptosis rate in MLE-12 cells. Mon suppressed the concentrations and protein expressions of proinflammatory factors, and the expressions of fibrosis-related proteins in LPS-challenged MLE-12 cells compared with LPS treatment alone. Mechanically, Mon downregulated the levels of NF-κB pathway, which was confirmed with the application of the receptor activator of nuclear factor-κB ligand (RANKL). Correspondingly, RANKL reversed the ameliorative effect of Mon on the proliferation, Apoptosis, inflammation and fibrosis. Moreover, Mon improved the pathological manifestations, Apoptosis, the W/D ratio and pulmonary function indicators in CLP-treated mice. Consistently, Mon attenuated inflammation, fibrosis and NF-κB pathway in CLP-treated mice.

Conclusion: Mon inhibited Apoptosis, inflammation and fibrosis to alleviate sepsis-evoked ALI via the NF-κB pathway.

NF-κB; fibrosis; inflammation; monotropein; sepsis-induced acute lung injury.